GlassScriptPhysician profile
Sonal R Patel
NPI 1336344357
$5,763.45
in general payments reported to CMS, 2019-2025
28 companies · $3,037 in 2025
The $3,037 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $269 · 2024: $2,458 · 2025: $3,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,594 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,594.45 |
| Education | $169.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $928.17 | 2023-2025 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $684.40 | 2024-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $611.68 | 2023-2025 | Enbrel, Evenity, Otezla |
| Glaxosmithkline, LLC. | $470.64 | 2024-2025 | Benlysta, Nucala |
| Ucb, INC. | $458.11 | 2024-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $396.93 | 2024-2025 | |
| Abbott Laboratories | $315.73 | 2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $281.80 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $274.08 | 2023-2025 | |
| Lilly USA, LLC | $227.94 | 2023-2025 | Zepbound, Mounjaro, Taltz |
| E.R. Squibb & Sons, L.L.C. | $187.10 | 2024-2025 | Orencia, Eliquis |
| Cequr Corporation | $144.31 | 2025 | Cequr Simplicity |
| Novartis Pharmaceuticals Corporation | $111.25 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.25 | 2024-2025 | Ofev, Jascayd |
| Vivus LLC | $78.61 | 2024 | Qsymia |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $66.83 | 2023-2025 | Tymlos |
| Exact Sciences Corporation | $62.49 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sobi, INC | $49.14 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $48.67 | 2025 | Acthar |
| Fresenius Kabi USA, LLC | $47.09 | 2023-2024 | Idacio |
| Ani Pharmaceuticals, INC. | $43.03 | 2023-2024 | Purified Cortrophin Gel |
| Sandoz INC. | $34.70 | 2024 | Hyrimoz |
| Dexcom, INC. | $32.34 | 2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $22.97 | 2025 | Austedo Xr |
| Inspire Medical Systems, INC. | $20.12 | 2024 | Inspire |
| Coopersurgical, INC. | $20.02 | 2025 | Paragard T 380a |
| Kiniksa Pharmaceuticals International, Plc | $18.48 | 2024 | Arcalyst |
| Organon LLC | $17.57 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.